Cargando…

Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy

PURPOSE: To investigate the macular microvascular changes after different kinds of chemotherapy in patients with extramacular retinoblastoma (RB). METHODS: In this study, 28 eyes of 19 patients with bilateral RB treated with intravenous systemic chemotherapy (IVSC group) and 12 eyes of 12 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Riazi-Esfahani, Hamid, Shamouli, Hadi, Pour, Elias Khalili, Fadakar, Kaveh, Khodabandeh, Alireza, Masoomian, Babak, Hatami, Vahid, Ghassemi, Fariba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170976/
https://www.ncbi.nlm.nih.gov/pubmed/37180523
http://dx.doi.org/10.4103/joco.joco_323_21
_version_ 1785039332088741888
author Riazi-Esfahani, Hamid
Shamouli, Hadi
Pour, Elias Khalili
Fadakar, Kaveh
Khodabandeh, Alireza
Masoomian, Babak
Hatami, Vahid
Ghassemi, Fariba
author_facet Riazi-Esfahani, Hamid
Shamouli, Hadi
Pour, Elias Khalili
Fadakar, Kaveh
Khodabandeh, Alireza
Masoomian, Babak
Hatami, Vahid
Ghassemi, Fariba
author_sort Riazi-Esfahani, Hamid
collection PubMed
description PURPOSE: To investigate the macular microvascular changes after different kinds of chemotherapy in patients with extramacular retinoblastoma (RB). METHODS: In this study, 28 eyes of 19 patients with bilateral RB treated with intravenous systemic chemotherapy (IVSC group) and 12 eyes of 12 patients with unilateral RB treated with intra-arterial chemotherapy (IAC group) were compared with 6 normal fellow eyes of 6 patients with unilateral RB treated with IVSC (IVSC fellow eye group), and 7 normal fellow eyes of 7 unilateral RB patients treated with IAC (IAC fellow eye group), as well as 12 age-matched normal eyes. Enhanced depth imaging optical coherence tomography measurements of central macular and subfoveal choroidal thickness (CMT and SFCT) as well as optical coherence tomography angiography measurements such as retinal superficial capillary density (SCD), deep capillary density (DCD), and choriocapillaris density were documented. RESULTS: Images of 2 eyes in the IVSC group and 8 eyes in the IAC group were excluded from the final image analysis due to severe retinal atrophy. Overall, 26 eyes with bilateral RB treated with IVSC and 4 eyes of 4 patients with unilateral RB treated with IAC were compared with the mentioned control groups. Best-corrected visual acuity was 1.03 logMAR in the IAC patients compared to 0.46 logMAR in the IVSC group at the time of imaging. While the CMT and SFCT were lower in the IAC group in comparison with the IAC fellow eye and normal groups (P < 0.05 for all), no remarkable difference was observed between the IVSC group and the control groups based on the mentioned parameters. Although the SCD showed no significant difference between the IVSC and control groups, this parameter was significantly lower in the eyes receiving IAC relative to the corresponding fellow eye group (P = 0.042) and normal control eyes (P = 0.047). The mean DCD was considerably lower in both the treatment groups compared to the control groups (P < 0.05 for all). CONCLUSION: Our study showed a substantial decrease in SCD, DCD, CMT, and choroidal thickness in the IAC group, which may explain the lower visual outcome in this group.
format Online
Article
Text
id pubmed-10170976
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-101709762023-05-11 Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy Riazi-Esfahani, Hamid Shamouli, Hadi Pour, Elias Khalili Fadakar, Kaveh Khodabandeh, Alireza Masoomian, Babak Hatami, Vahid Ghassemi, Fariba J Curr Ophthalmol Original Article PURPOSE: To investigate the macular microvascular changes after different kinds of chemotherapy in patients with extramacular retinoblastoma (RB). METHODS: In this study, 28 eyes of 19 patients with bilateral RB treated with intravenous systemic chemotherapy (IVSC group) and 12 eyes of 12 patients with unilateral RB treated with intra-arterial chemotherapy (IAC group) were compared with 6 normal fellow eyes of 6 patients with unilateral RB treated with IVSC (IVSC fellow eye group), and 7 normal fellow eyes of 7 unilateral RB patients treated with IAC (IAC fellow eye group), as well as 12 age-matched normal eyes. Enhanced depth imaging optical coherence tomography measurements of central macular and subfoveal choroidal thickness (CMT and SFCT) as well as optical coherence tomography angiography measurements such as retinal superficial capillary density (SCD), deep capillary density (DCD), and choriocapillaris density were documented. RESULTS: Images of 2 eyes in the IVSC group and 8 eyes in the IAC group were excluded from the final image analysis due to severe retinal atrophy. Overall, 26 eyes with bilateral RB treated with IVSC and 4 eyes of 4 patients with unilateral RB treated with IAC were compared with the mentioned control groups. Best-corrected visual acuity was 1.03 logMAR in the IAC patients compared to 0.46 logMAR in the IVSC group at the time of imaging. While the CMT and SFCT were lower in the IAC group in comparison with the IAC fellow eye and normal groups (P < 0.05 for all), no remarkable difference was observed between the IVSC group and the control groups based on the mentioned parameters. Although the SCD showed no significant difference between the IVSC and control groups, this parameter was significantly lower in the eyes receiving IAC relative to the corresponding fellow eye group (P = 0.042) and normal control eyes (P = 0.047). The mean DCD was considerably lower in both the treatment groups compared to the control groups (P < 0.05 for all). CONCLUSION: Our study showed a substantial decrease in SCD, DCD, CMT, and choroidal thickness in the IAC group, which may explain the lower visual outcome in this group. Wolters Kluwer - Medknow 2023-04-29 /pmc/articles/PMC10170976/ /pubmed/37180523 http://dx.doi.org/10.4103/joco.joco_323_21 Text en Copyright: © 2023 Journal of Current Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Riazi-Esfahani, Hamid
Shamouli, Hadi
Pour, Elias Khalili
Fadakar, Kaveh
Khodabandeh, Alireza
Masoomian, Babak
Hatami, Vahid
Ghassemi, Fariba
Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy
title Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy
title_full Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy
title_fullStr Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy
title_full_unstemmed Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy
title_short Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy
title_sort retinal optical coherence tomography angiography findings following retinoblastoma treatment by chemotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170976/
https://www.ncbi.nlm.nih.gov/pubmed/37180523
http://dx.doi.org/10.4103/joco.joco_323_21
work_keys_str_mv AT riaziesfahanihamid retinalopticalcoherencetomographyangiographyfindingsfollowingretinoblastomatreatmentbychemotherapy
AT shamoulihadi retinalopticalcoherencetomographyangiographyfindingsfollowingretinoblastomatreatmentbychemotherapy
AT poureliaskhalili retinalopticalcoherencetomographyangiographyfindingsfollowingretinoblastomatreatmentbychemotherapy
AT fadakarkaveh retinalopticalcoherencetomographyangiographyfindingsfollowingretinoblastomatreatmentbychemotherapy
AT khodabandehalireza retinalopticalcoherencetomographyangiographyfindingsfollowingretinoblastomatreatmentbychemotherapy
AT masoomianbabak retinalopticalcoherencetomographyangiographyfindingsfollowingretinoblastomatreatmentbychemotherapy
AT hatamivahid retinalopticalcoherencetomographyangiographyfindingsfollowingretinoblastomatreatmentbychemotherapy
AT ghassemifariba retinalopticalcoherencetomographyangiographyfindingsfollowingretinoblastomatreatmentbychemotherapy